Implementation of a fluid balance control strategy in critically ill patients: POINCARE-2 trial process evaluation.


Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
24 Jul 2024
Historique:
received: 01 01 2024
accepted: 17 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: epublish

Résumé

POINCARE-2 trial aimed to assess the effectiveness of a strategy designed to tackle fluid overload through daily weighing and subsequent administration of treatments in critically ill patients. Even in highly standardized care settings, such as intensive care units, effectiveness of such a complex intervention depends on its actual efficacy but also on the extent of its implementation. Using a process evaluation, we aimed to provide understanding of the implementation, context, and mechanisms of change of POINCARE-2 strategy during the trial, to gain insight on its effectiveness and inform the decision regarding the dissemination of the intervention. We conducted a mixed-method process evaluation following the Medical Research Council guideline. Both quantitative data derived from the trial, and qualitative data from semi-structured interviews with professionals were used to explain implementation, mechanisms of change of the POINCARE-2 strategy, as well as contextual factors potentially influencing implementation of the strategy. Score of actual exposure to the strategy ranged from 29.1 to 68.2% during the control period, and from 61.9 to 92.3% during the intervention period, suggesting both potential contamination and suboptimal fidelity to the strategy. Lack of appropriate weighing devices, lack of human resources dedicated to research, pre-trial rooted prescription habits, and anticipated knowledge of the strategy have been identified as the main barriers to optimal implementation of the strategy in the trial context. Both contamination and suboptimal fidelity to POINCARE-2 strategy raised concerns about a potential bias towards the null of intention-to-treat (ITT) analyses. However, optimal fidelity seemed reachable. Consequently, a clinical strategy should not be rejected solely on the basis of the negativity of ITT analyses' results. Our findings showed that, even in highly standardized care conditions, the implementation of clinical strategies may be hindered by numerous contextual factors, which demonstrates the critical importance of assessing the viability of an intervention, prior to any evaluation of its effectiveness. Number NCT02765009.

Sections du résumé

BACKGROUND BACKGROUND
POINCARE-2 trial aimed to assess the effectiveness of a strategy designed to tackle fluid overload through daily weighing and subsequent administration of treatments in critically ill patients. Even in highly standardized care settings, such as intensive care units, effectiveness of such a complex intervention depends on its actual efficacy but also on the extent of its implementation. Using a process evaluation, we aimed to provide understanding of the implementation, context, and mechanisms of change of POINCARE-2 strategy during the trial, to gain insight on its effectiveness and inform the decision regarding the dissemination of the intervention.
METHODS METHODS
We conducted a mixed-method process evaluation following the Medical Research Council guideline. Both quantitative data derived from the trial, and qualitative data from semi-structured interviews with professionals were used to explain implementation, mechanisms of change of the POINCARE-2 strategy, as well as contextual factors potentially influencing implementation of the strategy.
RESULTS RESULTS
Score of actual exposure to the strategy ranged from 29.1 to 68.2% during the control period, and from 61.9 to 92.3% during the intervention period, suggesting both potential contamination and suboptimal fidelity to the strategy. Lack of appropriate weighing devices, lack of human resources dedicated to research, pre-trial rooted prescription habits, and anticipated knowledge of the strategy have been identified as the main barriers to optimal implementation of the strategy in the trial context.
CONCLUSIONS CONCLUSIONS
Both contamination and suboptimal fidelity to POINCARE-2 strategy raised concerns about a potential bias towards the null of intention-to-treat (ITT) analyses. However, optimal fidelity seemed reachable. Consequently, a clinical strategy should not be rejected solely on the basis of the negativity of ITT analyses' results. Our findings showed that, even in highly standardized care conditions, the implementation of clinical strategies may be hindered by numerous contextual factors, which demonstrates the critical importance of assessing the viability of an intervention, prior to any evaluation of its effectiveness.
TRIAL REGISTRATION BACKGROUND
Number NCT02765009.

Identifiants

pubmed: 39048932
doi: 10.1186/s12874-024-02288-1
pii: 10.1186/s12874-024-02288-1
doi:

Banques de données

ClinicalTrials.gov
['NCT02765009']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160

Informations de copyright

© 2024. The Author(s).

Références

Oakley A, Strange V, Bonell C, Allen E, Stephenson J, RIPPLE Study Team. Process evaluation in randomised controlled trials of complex interventions. BMJ. 2006;332(7538):413–6.
doi: 10.1136/bmj.332.7538.413 pubmed: 16484270 pmcid: 1370978
Harvey LA, Jan S. Process evaluations for large clinical trials involving complex interventions. Spinal Cord. 2017;55(11):963–963.
doi: 10.1038/sc.2017.107 pubmed: 29099097
Petticrew M. When are complex interventions complex? When are simple interventions simple? Eur J Public Health. 2011;21(4):397–8.
doi: 10.1093/eurpub/ckr084 pubmed: 21771736
Hawe P, Shiell A, Riley T. Complex interventions: how out of control can a randomised controlled trial be? BMJ. 2004;328(7455):1561–3.
doi: 10.1136/bmj.328.7455.1561 pubmed: 15217878 pmcid: 437159
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.
doi: 10.1136/bmj.a1655 pubmed: 18824488 pmcid: 2769032
Wells M, Williams B, Treweek S, Coyle J, Taylor J. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions. Trials. 2012;13(1):95.
doi: 10.1186/1745-6215-13-95 pubmed: 22742939 pmcid: 3475073
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.
doi: 10.1136/bmj.h1258 pubmed: 25791983 pmcid: 4366184
Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061.
doi: 10.1136/bmj.n2061 pubmed: 34593508 pmcid: 8482308
Raine R, Fitzpatrick R, de Pury J. Challenges, solutions and future directions in evaluative research. J Health Serv Res Policy. 2016;21(4):215–6.
doi: 10.1177/1355819616664495 pubmed: 27522068
Agrinier N, Monnier A, Argaud L, Bemer M, Virion JM, Alleyrat C, et al. Effect of fluid balance control in critically ill patients: design of the stepped wedge trial POINCARE-2. Contemp Clin Trials. 2019;83:109–16.
doi: 10.1016/j.cct.2019.06.020 pubmed: 31260794
Bollaert PE, Monnier A, Schneider F, Argaud L, Badie J, Charpentier C, et al. Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trial. Crit Care. 2023;27(1):66.
doi: 10.1186/s13054-023-04357-1 pubmed: 36810101 pmcid: 9945675
Wright CC, Sim J. Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis. J Clin Epidemiol. 2003;56(9):833–42.
doi: 10.1016/S0895-4356(03)00155-0 pubmed: 14505767
Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, et al. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018;363:k1614.
doi: 10.1136/bmj.k1614 pubmed: 30413417 pmcid: 6225589
May C, Finch T, Mair F, Ballini L, Dowrick C, Eccles M, et al. Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res. 2007;7(1):148.
doi: 10.1186/1472-6963-7-148 pubmed: 17880693 pmcid: 2089069
O’Cathain A, Murphy E, Nicholl J. The quality of mixed methods studies in health services research. J Health Serv Res Policy. 2008;13(2):92–8.
doi: 10.1258/jhsrp.2007.007074 pubmed: 18416914
Polit DF, Beck CT. Generalization in quantitative and qualitative research: myths and strategies. Int J Nurs Stud. 2010;47(11):1451–8.
doi: 10.1016/j.ijnurstu.2010.06.004 pubmed: 20598692
Turner-Bowker DM, Lamoureux RE, Stokes J, Litcher-Kelly L, Galipeau N, Yaworsky A, et al. Informing a priori sample size estimation in qualitative Concept Elicitation interview studies for clinical Outcome Assessment Instrument Development. Value Health. 2018;21(7):839–42.
doi: 10.1016/j.jval.2017.11.014 pubmed: 30005756
Faulkner SL, Trotter SP. Data Saturation. In: The International Encyclopedia of Communication Research Methods [Internet]. American Cancer Society; 2017 [cited 2020 Dec 8]. pp. 1–2. https://onlinelibrary.wiley.com/doi/abs/ https://doi.org/10.1002/9781118901731.iecrm0060
Marshall B, Cardon P, Poddar A, Fontenot R. Does sample size matter in qualitative research? A review of qualitative interviews in is Research. J Comput Inform Syst. 2013;54(1):11–22.
Moser A, Korstjens I, Series. Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. Eur J Gen Pract. 2017;24(1):9–18.
doi: 10.1080/13814788.2017.1375091 pubmed: 29199486 pmcid: 5774281
Polit DF, Beck CT. Nursing research: Generating and assessing evidence for nursing practice. Lippincott Williams & Wilkins; 2008. p. 827.
Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533–44.
doi: 10.1007/s10488-013-0528-y pubmed: 24193818 pmcid: 4012002
Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.
doi: 10.1186/1471-2288-13-117 pubmed: 24047204 pmcid: 3848812
O’Connor C, Joffe H. Intercoder Reliability in Qualitative Research: debates and practical guidelines. Int J Qualitative Methods. 2020;19:160940691989922.
doi: 10.1177/1609406919899220
Morse JM. Approaches to qualitative-quantitative methodological triangulation. Nurs Res. 1991;40(2):120–3.
doi: 10.1097/00006199-199103000-00014 pubmed: 2003072
Bissell BD, Laine ME, Thompson Bastin ML, Flannery AH, Kelly A, Riser J, et al. Impact of protocolized diuresis for de-resuscitation in the intensive care unit. Crit Care. 2020;24(1):70.
doi: 10.1186/s13054-020-2795-9 pubmed: 32111247 pmcid: 7048112
Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50(6):952–7.
doi: 10.1053/j.ajkd.2007.08.016 pubmed: 18037096
Hellyer TP, McAuley DF, Walsh TS, Anderson N, Conway Morris A, Singh S, et al. Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation. Lancet Respiratory Med. 2020;8(2):182–91.
doi: 10.1016/S2213-2600(19)30367-4
Murdoch J. Process evaluation for complex interventions in health services research: analysing context, text trajectories and disruptions. BMC Health Serv Res. 2016;16(1):407.
doi: 10.1186/s12913-016-1651-8 pubmed: 27538946 pmcid: 4990981
Kivits J, Ricci L, Minary L. Interdisciplinary research in public health: the ‘why’ and the ‘how’. J Epidemiol Community Health. 2019;73(12):1061–2.
doi: 10.1136/jech-2019-212511 pubmed: 31594788
Healy P, Smith V, Savage G, Clarke M, Devane D, Gross MM, et al. Process evaluation for OptiBIRTH, a randomised controlled trial of a complex intervention designed to increase rates of vaginal birth after caesarean section. Trials. 2018;19(1):9.
doi: 10.1186/s13063-017-2401-x pubmed: 29304837 pmcid: 5756437

Auteurs

Marie Buzzi (M)

CIC, Epidémiologie Clinique, CHRU-Nancy, INSERM, Université de Lorraine, Nancy, F-54000, France. m.buzzi@chru-nancy.fr.
Université de Lorraine, Inserm, INSPIIRE, Nancy, F-54000, France. m.buzzi@chru-nancy.fr.
CIC-EC, CHRU Nancy Hôpitaux de Brabois, 9 allée du Morvan, Vandoeuvre-lès-Nancy, 54500, France. m.buzzi@chru-nancy.fr.

Laetitia Ricci (L)

CIC, Epidémiologie Clinique, CHRU-Nancy, INSERM, Université de Lorraine, Nancy, F-54000, France.
Université de Lorraine, Inserm, INSPIIRE, Nancy, F-54000, France.

Sébastien Gibot (S)

Service de Réanimation Médicale, CHRU Nancy, Université de Lorraine, Nancy, F-54000, France.

Laurent Argaud (L)

Service de réanimation médicale, Hospices civils de Lyon, Hôpital Edouard Herriot, Lyon, F-69000, France.

Julio Badie (J)

Service de Réanimation médicale, Hôpital Nord Franche-Comté, Belfort, F-90015, France.

Cédric Bruel (C)

Service de réanimation polyvalente, Groupe hospitalier Paris Saint-Joseph, Paris, F-75000, France.

Claire Charpentier (C)

CHRU-Nancy, Service d'Anesthésie Réanimation chirurgicale, Université de Lorraine, Nancy, F-54000, France.

Hervé Outin (H)

Service de Réanimation, CHI Poissy Saint-Germain, Poissy, F-78303, France.

Guillaume Louis (G)

Service de Réanimation polyvalente, CHR Metz-Thionville, Metz, F-57000, France.

Alexandra Monnier (A)

Service de Réanimation médicale, CHRU Strasbourg, Nouvel Hôpital Civil, Strasbourg, F-67000, France.

Jean-Pierre Quenot (JP)

Service de Médecine Intensive-Réanimation, CHU Dijon-Bourgogne, Dijon, F-21000, France.

Francis Schneider (F)

Service de Médecine Intensive Réanimation, CHU Strasbourg, Hôpital de Hautepierre, INSERM U 1121, Strasbourg, F-67000, France.

Laetitia Minary (L)

Université de Lorraine, Inserm, INSPIIRE, Nancy, F-54000, France.

Nelly Agrinier (N)

CIC, Epidémiologie Clinique, CHRU-Nancy, INSERM, Université de Lorraine, Nancy, F-54000, France.
Université de Lorraine, Inserm, INSPIIRE, Nancy, F-54000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH